Clinical evolution

Gates Foundation enlists Novartis, GSK, others in COVID-19 fight

27-Mar-2020 By Jenni Spinner

The global collaboration brings together several pharmaceutical giants to accelerate the development and delivery of coronavirus tests and therapies.

MedPharm expands drug discovery lab facilities

26-Mar-2020 By Jenni Spinner

The newly expanded facility in Research Triangle park features a range of larger and added laboratory spaces, including a dedicated innovation lab.

FDA roundup of COVID-19 responses

25-Mar-2020 By Jenni Spinner

The federal agency has been busy in recent weeks, taking actions and issuing advice in the face of the global coronavirus pandemic.

ProBioGen, Immunogenesis in cell line development agreement

24-Mar-2020 By Vassia Barba

Immunogenesis is tapping into ProBioGen’s manufacturing capabilities for its immuno-oncology lead candidate, as the potential treatment enters the clinic.

Trial management service available for free amid COVID-19 pandemic

23-Mar-2020 By Vassia Barba

Nubilaria joins a wave of providers that is offering their services for free to researchers working on potential treatments for COVID-19, with its ACTide EDC web platform.

TrialJectory matches cancer patients, clinical trials

23-Mar-2020 By Jenni Spinner

The AI-assisted platform, created by a cancer survivor, connects oncology patients with care options in an online marketplace.

Eli Lilly shifts clinical trial activity during coronavirus

23-Mar-2020 By Jenni Spinner

The pharmaceutical company has announced several changes to its clinical trial activities in the face of the global pandemic.

Demand for remote clinical management explodes due to coronavirus

19-Mar-2020 By Vassia Barba

CluePoints sees demand on services supporting remote clinical trials management ‘dramatically’ increase amid the ongoing coronavirus pandemic.

FDA issues coronavirus guidance for clinical trials

19-Mar-2020 By Jenni Spinner

The document offers pointers for the industry, investigators and institutional review boards operating trials in the face of the coronavirus pandemic.

ViiV Healthcare, UNC extend HIV partnership

19-Mar-2020 By Jenni Spinner

Funding has been extended for the public-private collaboration, which unites academic and pharma researchers on discovering HIV treatments.

Pharma events update: rescheduled, canceled, online

18-Mar-2020 By Jenni Spinner

This list includes the industry events that have been postponed or moved because of the coronavirus pandemic.

AR company offers coronavirus-safe collaboration kits

17-Mar-2020 By Jenni Spinner

Apprentice is sending sets of technology tools to pharmaceutical research and manufacturing facilities, including its Tandem AR collaboration platform.